Quinazoline Sulfonamides as Dual Binders of the Proteins B-Cell Lymphoma 2 and B-Cell Lymphoma Extra Long with Potent Proapoptotic Cell-Based Activity-Reference-Cited by-同舟云学术

Quinazoline Sulfonamides as Dual Binders of the Proteins B-Cell Lymphoma 2 and B-Cell Lymphoma Extra Long with Potent Proapoptotic Cell-Based Activity

Published:2011-03-02 Issue:6 Volume:54 Page:1914-1926
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Sleebs Brad E.¹²,Czabotar Peter E.¹²,Fairbrother Wayne J.³,Fairlie W. Douglas¹²,Flygare John A.³,Huang David C. S.¹²,Kersten Wilhelmus J. A.¹²,Koehler Michael F. T.³,Lessene Guillaume¹²,Lowes Kym¹²,Parisot John P.¹²,Smith Brian J.¹²,Smith Morey L.⁴,Souers Andrew J.⁴,Street Ian P.¹²,Yang Hong¹²,Baell Jonathan B.¹²

Affiliation:

1. The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, Australia

2. Department of Medical Biology, University of Melbourne, Parkville, Victoria 3010, Australia

3. Departments of Discovery Chemistry and Protein Engineering, Genentech, Inc. 1 DNA Way, South San Francisco, California 94080, United States

4. Cancer Research, Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm101596e

Reference28 articles.

1. Killing cancer cells by flipping the Bcl-2/Bax switch

2. Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets

3. The Hallmarks of Cancer

4. The Bcl-2 apoptotic switch in cancer development and therapy

5. BH3-only proteins in cell death initiation, malignant disease and anticancer therapy

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diverse models of cavity engineering in enzyme modification: Creation, filling, and reshaping;Biotechnology Advances;2024-05

2. B‐cell lymphoma‐2 family proteins in the crosshairs: Small molecule inhibitors and activators for cancer therapy;Medicinal Research Reviews;2023-11-20

3. Design, molecular modelling and synthesis of novel benzothiazole derivatives as BCL-2 inhibitors;Scientific Reports;2023-09-20

4. Design, Molecular Modelling and Synthesis of Novel Benzothiazole Derivatives as BCL-2 inhibitors;2023-03-17

5. Sulfonamide derivatives mediate breast and lung cancer cell line killing through tubulin inhibition;Journal of Molecular Structure;2022-11